Equillium Inc
IPO News: Equillium Prices 4.7mm Share IPO at $14, the bottom of the $14.00 - $16.00 Marketing Range
Equillium Inc

Equillium

NASDAQ:  EQ

Initial Filing Date:  09/17/18

Launch Date:  10/02/18

Pricing Date:  10/12/18

IPO Price:  $14.00

Price Range:  $14.00 - $16.00

Initial Shares Offered (mm):  4.7

Shares Offered (Pre-Shoe | mm):  4.7

Primary Shares (mm):  4.7

Secondary Shares (mm):  0.0

Amount Offered (mm):  $65.8

% Secondary:  0.0%

Shares Outstanding (mm):  16.7

Market Value at Pricing (mm):  $233.8

Offering as % of Market Value:  28.1%

Bookrunners:  JEFF | LEER | STFL

Major Holder:  Biocon | BioBrit | Steel Family Revocable Trust | Named Executives & Directors   

Industry:  Healthcare

Description:  Equillium is a biotechnology company leveraging deep understanding of immunobiology to develop products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need.

Note:  Emerging Growth Company